Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate in Type 2 Diabetes
NCT00392678Phase 3Completed
- Sponsor
- Joslin Diabetes Center
- Start
- Oct 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Amigesic in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Joslin Diabetes Center. Primary endpoint: Change in HbA1c at 14 weeks. Started Oct 2006; status: completed.
02
Drugs
Amigesic
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00392678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00392678.